NCT05966909

Brief Summary

In this prospective cohort study, the investigators evaluated the incidence of superficial vein thrombosis, deep vein thrombosis, and fibroblastic sleeve formation in solid cancer patients undergoing chemotherapy. The study aimed to shed light on the clinical progression of venous thrombosis in cancer patients with central venous catheters, with a particular focus on certain cancer types associated with a higher risk of venous thromboembolism (VTE). The investigators believe that such findings hold significant clinical relevance as a substantial portion of the study population was affected by pancreatic cancer, a cancer type known to carry a high risk of thrombotic events. This research adds valuable insights into understanding asymptomatic PICC-related thrombosis in this specific subgroup of cancer patients, which can aid in developing effective management strategies for venous access in this challenging population. The study employed an ultrasound-guided approach for follow-up at 30 and 90 days after catheter insertion, enabling us to detect and treat asymptomatic PICC-VTE in a timely manner. Identifying independent risk factors for catheter-related thrombosis, including age and cancer type, has further enhanced the clinical applicability of our findings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
Last Updated

August 2, 2023

Status Verified

August 1, 2023

Enrollment Period

3 years

First QC Date

July 21, 2023

Last Update Submit

August 1, 2023

Conditions

Keywords

Catheter-related thrombosisPeripherally inserted central catheter-portsCancer associated thrombosisUpper extremities vein thrombosis

Outcome Measures

Primary Outcomes (1)

  • Catheter related thrombosis

    Symptomatic and asymptomatic upper extremities thrombosis

    1 month and 3 months from baseline

Secondary Outcomes (1)

  • PICC vs PICC-PORT

    1 month and 3 months from baseline

Study Arms (1)

Solid cancer patients

Patients with solid cancer who underwent the placement of a PICC or PICC-PORT for chemotherapy.

Diagnostic Test: Doppler Ultrasound

Interventions

Doppler UltrasoundDIAGNOSTIC_TEST

Ultrasound diagnosi of asymptomatic and symptomatic upper extremities vein thrombosis

Solid cancer patients

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with solid cancer undergoing chemotherapy

You may qualify if:

  • patients with:
  • a documented active malignancy;
  • PICC or PORT placement for systemic chemotherapy;

You may not qualify if:

  • patients with:
  • a communication disorder;
  • contraindications to anticoagulation therapy;
  • hematopathy;
  • expected survival of less than one month;
  • were lost to follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliera Universitaria Integrata

Verona, 37134, Italy

Location

MeSH Terms

Interventions

Ultrasonography, Doppler

Intervention Hierarchy (Ancestors)

UltrasonographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mattia Cominacini, MD

    Azienda Ospedaliera Universitaria Integrata Verona

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 21, 2023

First Posted

August 1, 2023

Study Start

January 1, 2020

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

August 2, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations